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WORLD HEALTH ORGANISATION 
'HEALTHY LIFE EXPECTANCY IN 191 
COUNTRIES, 1999' - WHAT OF THE 
FUTURE? 
This important review,1 just published, concerns the present 
situation in a large number of countries regarding healthy life 
expectancy or disability-adjusted life expectancy years 
(DALEY), i.e. years of 'wellness'. By way of introduction and 
explanation, it was stated that 'years of healthy life lost due to 
disability represented 18% of total life expectancy with low 
healthy life expectancy countries, and decreases to around 8% 
in the countries with the highest healthy life expectancies. 
Globally, the male-female gapis lower for DALEY than for 
total life expectancy. Healthy life expectancy increases across 
countries at a faster rate than total life expectancy, suggesting 
that reductions in mortality rate are accompanied by 
reductions in disability. Although women live longer, they 
spend a greater amount of time with disability. As average 
levels of health expenditure per capita increase, healthy life 
expectancy increases at a greater rate than total life expectancy.' 
The lengthiest healthy life expectancy occurs among the 
Japanese (74.5 years). In second and third places are Australia 
and France, followed by a number of other industrialised 
countries in Western Europe. Surprisingly, the USA is ranked 
24th, with a healthy life expectancy of 70.0 years. 
Ranked lowest are several countries, largely in sub-Saharan 
Africa, where HIV-AIDS is most prevalent. Although in 143rd 
position, Gabon is most favourably placed at 48.3 years. South 
Africa ranks 160 at 39.8 years and Zimbabwe 184, with 32.9 
years. Sierra L~one is in the lowest position, listed 191, with 
25.9 years. It was stated that life expectancy in several 
countries in southern Africa has b~en
1 
reduced without HIV, 
and that other African countries have lost 5 - 10 years of life 
expectancy because of HIV. 
The immediate questions which arise are: from the distant 
past, just how far have we come? Among particular 
popu~ations or subpopulations, which are the most advanced 
in terms of healthy life expectancy? And, not least, given 
sustained and intense individual determination, what further 
gains could be made? Conversely, at the opposite extreme is 
the dire question regarding sub-Saharan African populations, 
especially those in southern Africa battling with the 
consequences of HIV I AIDS infection, namely how much lower 
is the already diminished life expectancy likely to fall? 
First, how far have we come? In the time of Aristotle, in the 
5th century BC, babies were not named for a week after birth 
since by then 'most' of them had died.' In the first century AD 
during the reign of the Emporer Augustus, a baby born to any 
mother could expect to live for 23 years.3 There was very little 
gain during the Middle Ages and in later centuries; indeed, in 
the UK as late as 1850 the average expectation of life among the 
very poor, namely the 'mechanics, servants, labourers', was 
only 16 years. Life expectancy increased to 26 years for 
'tradesmen', and to 45 years for 'gentlemen'.' However, it must 
be appreciated that those who did survive childhood enjoyed 
long lives, particularly so among the better circumstanced. 
There is evidence that well-off men and women in classical 
Rome' and in the Renaissance period' experienced life spans of 
50 - 60 years and longer. 
As to changes in infant mortality rate (IMR) and life 
expectancy, a century ago in the UK these were about 100 per 
1 000 live births and 50 years, respectively.6 In that country the 
IMR is currently 5 per 1 000 live births, and expectations of life 
about 75 years for men and 80 years for women.' Furthermore, 
in the near future, according to a fascinating editorial in the 
Lancet,8 'survival to 100 years or more may become the norm'. 
In the very gratifying situations described, to what extent 
can individuals or population subgroups, by strong 
deter~ination, still further increase their years of 'wellness', i.e. 
of healthy life expectancy? Some well-known examples include 
certain Mediterranean populations,' Seventh Day Adventists10 
and vegetarians. 11 These populations, whose lifestyles comply 
in large measure with officially strongly recommended health 
guidelines, have lower than average death rates from 
nutritionally related diseases, cardiovascular diseases and 
cancer, and they have longer years of 'wellness' and also longer 
survival times. In this field, regarding healthy life expectancy, a 
recent enquiry which has attracted world interest is the US 
Nurses' Health Study,12 established in 1976 and including 
121 700 female nurses. During the 14 years of follow-up the 
incidence of coronary heart disease declined by 31 % (it could 
have been greater, but for the rise in obesity). Smoking 
declined by 41 %, the use of hormone replacement therapy 
among post-menopausal women increased by 175%, and the 
diet consumed improved considerably. 
Probably the most spectacular example of what can be done 
is afforded by the California Mormons.13 A prospective study 
was carried out over 8 years on a cohort of about 6 000 
subjects, including middle-aged high priests and their wives 
who adhered to three health practices, namely never smoking 
cigarettes, engaging in regular physical activity, and getting 
· proper sleep. In order to calculate standardised mortality ratios ll'sa 
(SMRs) the white population of the USA was assigned a value m:All 
of 100. The SMR for the Mormon male group was 34 for all 
cancers, 14 for cardiovascular diseases and 22 for all causes. 
The corresponding SMRs for the wives of the priests were 55, 
34 and 47. These SMRs are among the lowest, if not the very 
lowest, on record. In commendation, it was stated that 'This 
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population is currently achieving the 50% reduction in cancer 
mortality that the US National Cancer Institute has set as a goal 
for the year 2000. These results demonstrate substantial 
progress in the prevention of cancer and other diseases in one 
well-defined population, and they suggest a lifestyle that could 
result in a major reduction in cancer mortality, as well as in 
mortality in general.' 
Are there any examples in developing populations of those 
who enjoy better than average health? Perhaps the most 
quoted example concerns the life experience in Kerala;1• one of 
the poorest provinces in India with a population of about 60 
million, and whose gross national product is only one-
hundredth of that in the UK. Due to various measures of 
community involvement and self-help, the IMR is low, about 
30 per 1 000 live births; elsewhere in India IMRs are 50 - 90 or 
more. In addition, Kerala, highly desirably, has a far lower 
birth rate, namely, 20 - 30 per 1 000 head of population, 
compared with that of India as a whole where the records 
show 40 - 50 per 1 000. 
Turning back to the situation in southern Africa - what was 
the situation in the past? At the turn of the last century in Cape 
Town, IMRs for both blacks and whites were very high at 304 
and 150 per 1 000 live births, respectively.1' Corresponding life 
expectancies were 31 and 47 years. Causes of death were 
almost wholly infections. At present, the IMR for blacks has 
fallen to 47 and for whites to 11 per 1 000 live births.16 
Interestingly, in 1995 the IMR in Soweto (population 3 million) 
had fallen to 20 per 1 000 live births.1' At that time life 
expectancies for black males and females were given as 60 and 
67 years, and for whites 69 and 76 years, respectively. The 
former vital statistics are probably the best in a sub-Saharan 
African population; indeed they approach those of some 
European populations.'Against the favourable situation 
described must now be juxtaposed the devastating situation 
with HIV I AIDS, perhaps southern Africa's holocaust. In South 
Africa, at present, approaching one-quarter or more blacks are 
infected.18 In some big city hospitals at least half of the patients 
now have HIV-related diseases.1' In the southern African 
countries most affected, it is considered likely that the infection 
will cause the early death of as many as 50% of teenagers,2° and 
that life expectancy will fall from 60 to 45 years. 21 " 2 Only a 
vaccine is likely to arrest increasing morbidity and mortality." 
Returning to developed populations, with the possibility of 
further increases in healthy life expectancies, it is clear that 
despite the undoubted benefits likely to arise from altering 
some aspects of lifestyle, the general public has little wish to 
make any changes. On the contrary, despite numerous health 
recommendations the undesirable situation is that in most 
populations the prevalence of obesity has doubled." 
Furthermore, in contrast to previous falls in smoking practice 
among the young, rises are occurring, as well as in alcohol 
consumption and drug taking.25•26 The general attitude in many 
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ways would seem to be that since life expectancy with today's 
mode of living is far longer than it was in the past, people want 
to live as they wish. 
Notwithstanding resistance to change it could be asked: in 
the ultimate, what is the ideal? In this regard there is the often-
quoted view that 'Nature did not intend us to grow old and 
ill; we were designed to die young, of old age, but free of 
disease ... We can prevent a substantial proportion of chronic 
diseases by improving lifestyle and preventive medicine. 
Healthy older persons can continue to be physically and 
intellectually productive and active in their 80s."' In this regard 
two authorities held in high international esteem maintain that 
'there is no such thing as aging: old age is associated with 
disease but not the cause of it' .2' 
This discussion of ideal health seems heartless when 
considering the heavy burden of ill-health and premature 
death in developing populations, with their invariably 
unfavourable socio-economic circumstances, especially among 
populations in sub-Saharan Africa. Nevertheless, even in these 
adverse contexts the health benefits that would result from 
reduced smoking practice, restricted alcohol consumption, and 
greater physical activity among urban dwellers should still be 
urged. 
In brief, developed, and to some extent urban developing 
populations could - with intense, indeed near-Herculean 
resolve - make alterations to their lifestyle that would 
assuredly lessen the current burden of ill-health, especially in 
middle and old age, and further extend life expectancy. 
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ASSESSING DIAGNOSTIC ACCURACY AND 
TYMPANOCENTESIS SKILLS OF SOUTH 
AFRICAN PHYSICIANS IN MANAGEMENT OF 
OTITIS MEDIA 
To the Editor: The distinction between acute suppurative otitis 
media (AOM) and otitis media with effusion (OME) is 
important for antibiotic management decisions;' 
tympanocentesis may be useful in the diagnosis of AOM in 
selected patients.' During visits to South Africa in 2000 and 
2001 I presented a continuing medical education (CME) course, 
which offered the opportunity to assess the accuracy of South 
African physicians with regard to physical examination 
findings of AOM and OME. Their technical competence in 
performing tympanocentesis was also assessed, and their 
performance was compared with that of practising United 
States physicians on both accounts. 
CME course participants viewed nine different video-
recorded pneumatic otoscopic examinations. Thereafter they 
were asked to reach a conclusion as to one of four possible 
diagnoses: AOM, OME, retracted but otherwise normal, and 
normal. 
The percentage of correct diagnoses by specialty and overall 
is shown in Table I, and is compared with performance by US 
physicians. There was remarkable consistency in the 
percentage of correct diagnoses according to specialty for those 
attending the course in South Africa and the USA Overall the 
average correct diagnosis for South African paediatricians was 
53%, and for otolaryngologists, 72%. Otolaryngologists tended 
to make the correct diagnosis of OME more often than 
paediatricians. 
Table I. Comparison of diagnostic accuracy of video-presented 




USA South Africa USA 
(N = 478) 
50 
South Africa 
(N = 36) 
53 
(N = 151) (N = 37) 
73 72 
To validate the skill of otolaryngologists and for training of 
paediatricians, a mannequin model was developed and 
validated as an effective training tool. The mannequin consists 
of a plastic external shell head and shoulders mould with an llD 
external pinna and auditory canal. A cartridge consisting of 
four simulated tympanic membranes inserts into the head 
portion of the mannequin. Each participant was allowed 15 
minutes to complete the four tympanocentesis procedures. 
Tympanocentesis performance results are presented in Table 
IL Above average familiarity with the procedures was observed 
